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The effect of hyperthyroidism on cardiac sensitivity no beta-
adrenergic stimulation in humans is controversial. To determine
whether heart rate and left ventricular contractile sensitivity to
betaadrenergic stimulation are altered by hyperthyroidism in
human subjects, the frequency, velocity and extent of left
ventric-
ular
shortening at rest and during a 4-stage graded dose isopro-
terenol infusion were characterized in eight young healthy sub-
jects before and after 2 weeks of daily administration of 100
Jag
of
triiodothyronine (Ts). The rate and extent of left ventricular
shortening were determined by Doppler add two-dimensionally
guided M-mode echocardiography .
In the hyperthyroid state, heart rate at rest was faster (57 ± 3
vs. 68 t 4 beats/min; p < 0.001) and the slope of the relation of
hurt rate to the rate of isoproterenol infusion was 36% steeper
(1,538 t 126 vs. 1,131 t 95 ; p < 0 .05) . The left ventricular
ejection lime was shorter and the mean velocity of left ventricular
circumferential fiber shortening (mVcf) was greater during all
Hyperthyroidism increases beta-adrenergic receptor density
and agonist sensitivity in the myocardium of several species
of experimental animals (1-8)
.
However, in humans the
effect of altered thyroid status on cardiac sensitivity to
beta-adrenergic stimulation is highly controversial
(9-15)
.
Although beta-adrenergic blockade is used therapeutically to
treat thyrotoxicosis, most previous investigations (11-15) in
human subjects have failed to detect evidence of enhanced
left ventricular contractile or heart rate sensitivity to cate-
cholamines in the hyperthyroid state . Possible explanations
for this paradox include the fact that earlier investigations of
cardiac responses to beta-adrenergic antagonists (13,14) or
epinephrine (11,12) either did not permit analysis of the
dose-agonist response relation or were confounded by other
effects of catecholamines such as alpha-adrenergic stimula-
tion . The latter are of major physiologic importance, but
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stages of isoprotereewl infusion in the hyperthyroid versus the
euthyraid state (p < 0
.01).
After adjanent far the faster heart rate after T a administra-
tion, left ventricular ejection time and mVef were similar in the
enthyroid and hyperthyroid states at baseline and diving maximal
beta-adrenergic stimulation but shurtened and enhanced, respec-
tively, during stages 1 and 2 of isoproterenol infusion (p < 0 .05).
There was no et el of Ts administration on left ventricular mass,
dimensions, endaystolic wag stress or stroke volume at rest ar
during any stage of isoprokreaol infusion.
These results indicate that in ban= subjects hyperlhyroidism
of short duration increases the sensitivity of hurt rate and left
ventricular shettenhr; velocity to beta-ardrenergic stimulation in
the absence of changes in left ventricular mass, goading conditions
or extent of shortening.
(J Am Call Candied 1943;19 :1195-97)
epinephrine elicits only a modest increase in heart rate in
comparison with selective beta-adrenergic agonises such as
isoproterenol (16). The cardiac stroke volume response to
isoproterenol was also found to be unaltered in the hyper-
thyroid state (15). However, hyperthyroidism enhances the
velocity rather than the extent of myocardial shortening in
experimental animals (17) and stroke volume is not a sensi-
tive or specific index of myocardial contractility .
Therefore, we hypothesized that the discrepant effects of
hyperthyroidism on cardiac beta-adrenergic sensitivity in
humans and experimental animals could be explained by
different effects on the velocity and extent of left ventricular
shortening during beta-adrenergic stimulation . Because left
ventricular loading conditions and mass influence cardiac
performance (18), are often altered by hyperthyroidism
(19,20) and were frequently not evaluated in earlier studies
of the effect of hyperthyroidism on left ventricular contrac-
tile responses to beta-adrenergic agonises or antagonists, a
second objective was to assess whether altered cardiac ;
loading conditions could account for the absence of in-
creased left ventricular beta-adrenergic sensitivity in pa-
tients with thyrotoxicosis . To test our hypotheses in human
subjects, we characterized the effect of mild to moderate
hyperthyroidism induced by short-term administration of
triiodothyronine on the velocity, extent and frequency of left
ventricular shortening and on simultaneous noninvasive
6735-1097I5LS5 .00
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estimates of left ventricular mass and loading conditions
during a graded dose isoproterenol infusion .
Methods
Study subjects. Eight euthyroid subjects (four men and
four women) with a mean age (±SE) of 25 ± I years were
studied . Results of a medical history, physical examination,
rest electrocardiogram (ECG) and maximal exercise stress
test were normal in all participants . None took regular
medications, consumed caffeine-containing beverages or
smoked on days of laboratory visits . Subjects were studied
before and after a 2-week regimen of 100 pglday of oral
triiodothyronine (T5) . The protocol for this investigation was
approved on October 22, 1987 by the Human Studies Com-
mittee of Washington University with a yearly renewal since
that time . All subjects gave voluntary written informed
consent for participation in the study .
isoproterenol infusion protocol . This protocol was con-
ducted in the morning after an overnight fast at a similar time
of day in the euthyroid and hyperthyroid states . Doppler and
two-dimensional echocardiographic examinations were per-
formed after 15 to 30 min of supine rest and during the latter
5 min of each of 4 stages of a graded dose isoproterenol
infusion, A calibrated model 22 Harvard infusion pump was
used to infuse isoproterenol into a forearm vein at rates of
0 .01, 0.02, 0.03 and 0.04 cg/kg per min, respectively, in
stages I to 4 (21) . The infusion was terminated after stage 3
at the request of one subject because of palpitation associ-
ated with sinus tachycardia. However, there were no ar-
rhythmias or other adverse cardiac effects of the study .
During infusions, cardiac rhythm was monitored continu-
ously by oscilloscope . Heart rate was determined every
2 min from at least three consecutive RR intervals of the
ECG . Blood pressure was measured with a cuff sphygmo-
manometer at 3, 6 and 10 min of each stage. Heart rate and
blood pressure remained stable between 6 and 10 min .
Therefore, data from these time intervals were averaged and
reported in the results .
Doppler and two-dimensional echocardiographic studies.
Two-dimensionally guided M-mode echocardiograms of the
left ventricle were obtained from the parasternat short-axis
view with use of a Hewlett-Packard model 77020A ultra-
sound imaging system equipped with a 2 .5-MHz model
21200B transducer. Recordings were made on light-sensitive
paper with the transducer positioned in the third or fourth
left intercostal space . The transducer position was docu-
mented and maintained constant during each stage and
before and after T5 administration . After echocardiograms of
the left ventricle were obtained, continuous wave Doppler
tracings of the ascending aorta were recorded from the
supracternal notch with use of a 1.9-MHz Hewlett-Packard
model 21221A transducer to characterize aortic flow velocity
and left ventricular ejection time . Subsequently, the aortic
outflow tract and root were visualized from the parasternal
long-axis position. Two-dimensional images of this view
(ccc V .I. 19, No. b
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were used to obtain M-made echocardiograms of the aortic
root and valve .
Left ventricular end-diastolic and end-systolic dimen-
sions (LVEDD and LVESD, respectively) were determined
according to recommendations of the American Society of
Echocardiography (22) . The coefficient of variation for mea-
surements of left ventricular dimensions during catechol-
amine infusion or exercise is <5% in our laboratory (23,24) .
At each stage of isoproterenol infusion, measurements were
made of at least five cardiac cycles that were consecutive
except for occasional exclusions for technical quality . The
extent of left ventricular shortening was quantified as frac-
tional shortening (FS%) by using the relation FS% =
I(LVEDD - LVESD)ILVEDD)] x 10001o. Left ventricular
ejection time (LVET) was measured from the onset to the
termination of at least five continuous wave Doppler tracings
of the ascending aorta. These beats were again consecutive
except in occasional instances . To assess the rate of left
ventricular shortening, the mean velocity of circumferential
fiber shortening (mVcf) was calculated as mVcf = FS%/
LVET. Because measurements of fractional shortening and
left ventricular ejection time were made on nonsimultaneous
beats, the heart rate of cardiac cycles used for echocardio-
graphic and Doppler measurements was determined and
compared . Differences in hear rate during the same stage of
isuproterenol infusion averaged 3 beats/min and were signif-
icant only during stage 2, in which echocardiographic and
Doppler study heart rates were 86 and 91 beats/min, respec-
tively (p < 0 .05) .
In the hyperthyroid state, heart rate was considerably
faster than in the euthyroid state (p < 0.001). To adjust for
these differences, the left ventricular ejection time was
corrected for heart rate (LVETC), as described by Colon
et al. (25), by using the relation LVETC = LVET/\R
--R
.
The mean velocity of left ventricular circumferential fiber
shortening was also corrected for heart rate by calculating
the quotient of fraction shortening and the left ventricular
ejection time corrected for heart rate .
To account for the effect of changes in q/tertoad, the
mean velocity of left ventricular circumferential fiber short-
ening was expressed as a function of left ventricular end-
systolic meridional wall stress . The latter was estimated
from cuff measurements of systolic blood pressure and
echocardiographic measurements of left ventricular dimen-
sions and posterior wall thickness at end-systole as de-
scribed by Reichek et al . (26). Left ventricular mass was
assessed from baseline short-axis M-mode echocardiograms
with the method of Troy et al . (27). Stroke volume was
determined as the difference between left ventricular end-
diastolic and end-systolic volume where both volumes were
estimated from respective linear dimensions of M-made
echocardiograms (27) .
Statistics, The statistical significance of effects of hyper-
thyroidism and isoproterenol infusion on left ventricular
function and other physiologic variables was evaluated by
tw -way analysis of variance. Differences between specific
JACC Vol. I9 . No. 6
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Figure 1. Effect of experimental hyperthyroidism on heart rate
during supine rest and in response to a graded dose isoproterenol
infusion
. Data are mean values ± SE . *`p < 0.01
; ***p < 0
.001
versus euthyroid values at the same stage.
means were identified by Student i tests for paired observa-
tions . The slope and intercept of equations describing heart
rate responses to isoproterenol in each subject before and
afterT3 administration were determined by linear regression
analysis . The effect of hyperthyroidism on these values was
then assessed by Student t tests for paired observations .
Differences in results were considered statistically signifi-
cant at p < 0.05
. Data are expressed as mean values .0 SE .
Results
Thyroid indexes . During initial studies, subjects were
cuthyroid as assessed by plasma T, and thyroid-stimulating
hormone levels (112 ± 10 ng/ml and 1 .7 ± 0 .3 µU/ml,
respectively). Two weeks of daily T3 administration in-
creased plasma T, concentration by 401%
(564 ± 141 ng/ml ;
p < 0
.001) and resulted in a decrease in thyroid-stimulating
hormone to 0.5 1AUlml in two subjects and to undetectable
levels in the other six subjects (p < 0 .001). Physiologic
manifestations of hyperthyroidism included a faster heart
rate at supine rest (68 ± 4 vs
. 57 ± 3 beats/min; p < 0.001),
a higher oxygen uptake at rest (0 .25 m 0.02 vs. 0.22 m 0.02
liters/min ; p = 0.05) as measured by automated respiratory
gas adalysis (28),
and a tendency to lose weight (715
.
5 vs.
72 .9 ± 5.4 kg ; p = 0.08) .
Heart rate (Fig. 1)
. isoproterenol elicited a progressive
increase in heart rate with no evidence of desensitization
during the 4 stages of infusion. By linear regression analysis
the correlation between isoproterenol infusion rate and heart
rate averaged 0.97 ± 0 .01 before T3 administration and 0.98
± 0.03 afterward. In the hyperthyroid state, the slope of the
regression line was 36% greater than in the euthyroid state
(1,538 ± 126 vs . 1,131 ± 95; p < 0.05), consistent with
enhanced heart rate sensitivity or responsiveness to beta-
adrenergic stimulation, or both . Peak heart rate in stage 4 of
isoproterenol infusion was 102 ± 4 beats/min in the euthy-
roid state and 129 ± 5 beats/min after T 3 administration
.
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Figure 2. Effect of experimental hyperthyroidism on audiac dimen-
sions (upper panel, A) . stroke volume (middle pod, B) and systolic
blood pressurefeft ventricular rod-systolic dimension (SBPI
LVESD) relation (lower panel, C) during supine rest and in response
to a graded dose isoproterenol infusion . Cardiac dimensions in
diastole and systole and stroke volume were determined echocar-
diographically . Data are mean values m SE.
Left ventricah r dam, fianctilina and mass (Fig. 2).
Baseline left ventricular dimensions, fractional shortening
and stroke volume were within the normal range and did not
change significantly after T3 administration (33 .3 ± 1 .7% vs .
33 .9 x 1 .3% for fractional shortening before vs. after T3
administration ; p = NS) . Aortic diameter, measured at the
level of the aortic valve, and baseline peak aortic flow
velocity also remained similar (2 .9 ± 0.2 vs. 2.9 ± 0.1 cm
and 102 .1 *_ 4.2 vs. 109 .8 ± 4
.2 ends, respectively ; p = NS).
Similarly, baseline systolic blood pressure and left ventric-
ular afterload, defined as end-systolic meridional wall stress,
were not altered by hyperthyroidism (112 ± 4 vs . 114
4 mm Hg and 58.6 ± 4.2 vs. 58.9 ± 4
.9 g/cm2, respectively ;
p = NS) . Finally, there was no evidence of left ventricular
hypertrophy in these subjects after 2 weeks of excess T3
administration (left ventricular mass = 137
.4 ± 13 .8 vs .
132 .9 '_ 12 .9 g before vs . after Ts;
p = NS). In contrast to
these findings, baseline left ventricular ejection time was
shorter and the mean velocity of left ventricular circumfer-
ential fiber shortening was faster after than before T, admin-
istration (0.28 ± 0.02 vs. 0.32 ± 0
.02 s and 1 .23 ± 0.1 vs . 1 .06
0
.06 diameters/s. respectively; p < 0.001 and p < 0 .05),
consistent with an increased left ventricular contractile
state
. However, when the baseline left ventricular ejection
time and the mean velocity of circumferential fiber shorten-
ing were adjusted for the faster heart rate induced by
hyperthyroidism, mesa differences were no longer signifi-
cant (0.31 ± 0.02 vs. 0.3 ± 0 .02 s and 1 .09 ± 0 .08 vs . 1 .18
1188
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Figum3. Effect of experimental hyperthyroidism on left venticWar
ejection time (LVET) (upper panel, A) determined by Doppler
echocardiography and the mean velocity of left ventricular circum-
ferenlial fiber shortening (mVcf) (lower panel, B) determined by
lwodimersionally guided M-mode and Doppler echocardiography
during supine rest and in response to a graded dose isoproterenol
infusion . ?iota are mean values ± SE . •p < 0.05; r*rp < 0.001
versus euthyroid values at the same stage .
0 .09 diameters/s, respectively, before and after Te adminis-
tration ; p = NS) .
Effects of hyperthyroidism on left venlricular eantraelite
responses to heta.adrenergic stimulation (Fig. 2 to 5)
. Graded
dose isoproterenol infusion markedly augmented the left
ventricular contractile state. This effect was demonstrated
by decreases in left ventricular end-systolic dimensions (Fig .
2), ejection time (Fig . 3) and ejection time currnUed fur heart
rate (Fig . 4) and by large increases in left ventricular
fractional
.shortening, stroke volume (Fig . 2), mean velocity
of circumferential fiber shortening (Figs
. 3 and 4 . respec-
tively; for results before and after correction for heart rate)
and the ratio of systolic blood pressure to left ventricular
end-systolic dimension (Fig . 2)
. These effects weru not
accompanied by a change in preload, defined as left ventric-
ular end-diastolic dimension (Fig- 2)- but they may have
been related in part to a decrease in afterload, quantified as
left ventricular end-systolic meridional wall stress (Fig, 5) .
The increase in left ventricular contractile state in response
to isoproterenol attained a plateau in stage 2 or 3 as assessed
by the absence of further changes in mean velocity of
circumferential fiber shortening, end-systolic dimension and
stroke volume (Fig
. 2 to 4), consistent with achievement of a
maximal left ventricular contractile response to bela-
adrenergic stimulation .
The magnitude of enhancement affruclional shortening
and stroke volume with tsaproterenol infusion was
similar
before arrd after ingestion of T3 (Fig. 2) . Thus, experimental
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Fgure 4. Effect of experimental nyperthynoidism on the left ven-
tricular ejection time corrected for heart rate (LV£TO)
(
upper panel,
A) determined by Doppler echocardiography and the mean velocity
of left ventricular circumferntial fiber shortening corrected for
heart rate (mVcfr) flower panel, B) determined by two-dimensionally
guided N-mode and Doppler echocardiography during supine rest
and in response to a graded dose isoproterenol infusion . Data are
mean values
.
SE . "p < 0.05 versus euthyroid values at the same
stage .
hyperthyroidism did not influence the extent of left ventric-
ular shortening in response to selective beta-adrenergic
stimulation . Aortic root diameter under these conditions was
also not altered by hyperthyroidism . In contrast, peak aortic
flow velocity during isoproterenol infusion tended to be
higher in the hyperthyroid state (p = 0
.10). The left ventric
ular ejection time, uncorrected for the faster heart rate after
T, administration, was significantly reduced (Fig
. 3) and the
rate of left ventricular shortening, quantified as the mean
velocity of circumferential fiber shortening (Fig . 3), was
increased in the hyperthyroid versus the euthyroid state at
More 5. Efect of experimental hyperthyroidism on the mean
velocity of left venaicular (LV) circumferential fiber shortening
(mVefl expressed as a function of aferload, defined as left ventric-
utarend-sysroRc wall stress
. Data am mean values r SE . ep < 0A5 ;
r"'p < 0.001 versus values for circumferential fiber shortening in
the euthyroid state.
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baseline and at all stages of isoproterenol infusion, even
though concurrent changes in afterload (Fig. 5) and preload
(Fig. 2) during the infusion were similar in both studies .
However, after adjustment of the left ventricular ejection
time and shortening velocity for the faster heart rate in the
hyperthyroid state, both measurements were similar before
and after T5 administration at baseline and at maximally
stimulating rates (stages 3 and 4) of isoproterenol infusion
(Fig
. 4).
In contrast, the left ventricular ejection time corrected for
heart rate was shorter during stages I and 2 and the mean
velocity of circumferential fiber shortening corrected for
heart rate was greater during stage I after T, administration,
providing evidence that isotropic sensitivity to selective
beta-adrenergic stimulation is increased by experimental
hyperthyroidism even in the absence of a change in the
extent of left ventricular shortening.
Discussion
Major findings in relation to previous
studies. In our study
2 weeks of excess triiodothyronine (T
5) administration re-
sulting in mild to moderate hyperthyroidism increased the
sensitivity of both heart rate and left ventricular shortening
velocity to beta-adrenergic stimulation in human subjects .
These effects occurred even though the extent of left ven-
tricular shortening was not enhanced and there were no
significant differences between the euthyroid and hyperthy-
roid states in left ventricular dimensions, mass or loading
conditions . Our results are consistent with studies in ex-
perimental animals demonstrating that thyroid hormones
increase myocardial beta-adrenergic receptor density
(2,3,7,8), amplify the cyclic adenosine monophosphate re-
sponse of cultured heart cells to epinephrine (41. enhance the
tachycardic response of isolated mouse hearts to submaxi-
mally stimulating doses of isoproterenol (I) and augment the
contractile response of isolated rat myocardium to low dose
beta-adrenergic stimulation (6). Paradoxically, other inves-
tigations (11-15) have suggested that results of these studies
are not applicable to human subjects. No augmentation of
human cardiovascular responses to catecholamines was ob-
served during T,-induced thyrotoxicosis (11 .12) and no
difference was found in the effect of beta-adrenergic block-
ade on heart rate or myocardial function of spontaneously
thyrotoxic and normal persons (13,14) . Similar to findings in
experimental animals, however, our data demonstrate that
hyperthyroidism increases the sensitivity of heart rate and
left ventricular shortening velocity to beta-adrenergic stim-
ulation in humans .
Effect of Ta administration on cardiac responses to isopro.
terenol. Most earlier studies (11-14) of the effect of hyper-
thyroidism on left ventricular function in humans either did
not examine the dose-response relation to beta-adrenergic
agonist administration or reported responses to epinephrine
or norepinephrine, Although these catecholamines are of
major physiologic importance, they also stimulate alpha-
1189
adrenergic receptors, evoke parasympathetic reflex activity,
alter cardiac loading conditions and elicit only a slight
increase or a decrease in heart rate in comparison with
isoproterenol (16)- Investigations of human cardiovascular
responses to isoproterenol(15) were performed before sen-
sitive noninvasive methods were available to quantify both
the velocity and the extent of left ventricular shortening
under physiologic conditions .
In our subjects, the response of left ventricular shortening
velocity to low dose isoproterenol infusion was enhanced
after T5 administration, a finding similar to previous obser-
vations in the myocardium of experimental animals
(1,6.8) .
At higher levels of beta-adrenergic stimulation that elicited a
plateau in the left ventricular contractile response, increases
in heart rate and in the absolute (uncorrected for heart rate)
velocity of left ventricular shortening were greater in the
hyperthyroid than in the euthyroid state . However, after
normalization of left ventricular shortening velocity for the
faster heart rate in the hyperthyroid state, no difference
between pre- and post-T, studies was found at maximally
stimulating isoproterenol infusion rates . The latter results
are in agreement with in vitro studies demonstrating no
T,-induced increase in the maximal velocity or extent of
myocardial shortening in response to catecholamines (6,17) .
Our findings are also consistent with previous data in hu-
mans showing no effect of induced hyperthyroidism on
stroke volume responses to the selective beta-adrenergic
agonist isoproterenol (15) and with the well known abbrevi-
ation of left ventricular ejection time by spontaneous thyro-
toxicosis (29) .
Left
ventricular leading conditions. Hyperthyroidism of-
ten results in reduced peripheral vascular resistance and
enhanced cardiac preload (19,20) . Such changes could con-
found interpretation of effects of T, on left ventricular
contractile function. Subjects who participated in the
present investigation were found to have a lower total
peripheral resistance (higher heart rate and cardiac output at
a similar mean blood pressure) after than before T, admin-
istration . However, tree myocardial afterload is thought to
be
most accurately quantified in terms of end-systolic me-
ridional wall stress (18). Reliable and reproducible tech-
niques to estimate wall stress noninvasively have been
developed (26). In our subjects, left ventricular afterload,
quantified in this manner, was not significantly altered by T,
administration either in baseline studies or during isoproter-
enol infusion . Thus, the effect of T 3 on the sensitivity of left
ventricular shortening velocity to isoproterenol is unlikely to
be related to decreased afterload in the hyperthyroid state
.
Similarly, there was no influence of T, on preload, defined as
left ventricular end-diastolic dimension . Although we did not
measure end-diastolic pressure, the absence of a change in
left ventricular end-diastolic diameter provides evidence that
myocardial fiber length was not increased in the hyperthy-
roid state (18). The conclusion that the T3 induced increase
in velocity of left ventricular shortening is not related to
effects on cardiac loading conditions is also consistent with
1190
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data of Goldman et al. (30) obtained in conscious thyrotoxic
calves .
Other cardiac effects of hyperthyroidism in experimental
animals
. In addition to altering responses to beta-adrenergic
stimulation, T3 elicits other cardiac effects in experimental
animals . These include tachycardia at rest, cardiac enlarge-
ment, hypertrophy, an enhanced contractile state and myo-
sin isoenzyme transformation (8,19)
. In our subjects exper-
imental hyperthyroidism induced tachycardia and an
augmented rate of left ventricular shortening, but hypertro-
phy, cardiac enlargement and an increased extent of left
ventricular contraction did not occur. Furthermore, the
reduction of left ventricular ejection time was partly related
to a faster heart rate. The explanation for the absence of
cardiac hypertrophy and enlargement in these human sub-
jects is unclear. However, considerable variation in thyroid
hormone-induced effects on the heart has been observed in
studies of different species of mammals (1,6-8,19). In addi-
tion, there were differences in the dosage and duration of
thyroid hormone treatment in those studies (1,6-8,19) and
very high doses were often given . Thus, it is not surprising
that some effects of T 3 reported in experimental animals
were not found in the present study .
Contrasting effects of hyperthyroidism on cardiac and
skeletal muscle. In a previous investigation (31), we ob-
served that the same T3 administration protocol used in the
current study to induce thyrotoxicosis resulted in skeletal
muscle atrophy and accelerated whole body protein catabo-
lism . In addition, beta-adrenergic receptor density in skeletal
muscle fibers was increased without a change in metabolic or
peripheral vascular sensitivity to isoproterenol (32). These
findings are in contrast to the maintenance of left ventricular
mass and enhancement of left ventricular sensitivity to
beta-adrenergic stimulation observed in the present investi-
gation
. However, disparate effects on skeletal and cardiac
muscle are consistent with evidence in experimental animals
(33,34) that hyperthyroidism enhances skeletal muscle pro-
tein breakdown while simultaneously increasing cardiac
mass
. Previous controversies regarding physiologic effects
of hyperthyroidism may be related in part to disparities such
as these
. Results of our studies emphasize the importance of
characterizing specific effects of hyperthyroidism in perti-
nent human target tissue .
Limitations. Patients with spontaneous hyperthyroidism
may have a variety of cardiac manifestations of thyrotoxi-
cosis including atrial tachyarrhythmias, cardiomegaly and
congestive heart failure (20) . The lack of these findings in our
subjects is probably due to their young age, the relatively
short duration of thyrotoxicosis and the absence of coexist-
ent cardiovascular disorders such as hypertension or coro-
nary artery disease
. For ethical reasons we did not consider
it appropriate to induce a hyperthyroid state for more than a
few weeks . Nevertheless . our subjects were clearly hyper-
thyroid on the basis of marked changes in plasma T3 and
thyroid-stimulating hormone concentrations and an in-
creased rest metabolic rate . Thus, our data are relevant to
JACC Vol. 19, No . 6
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otherwise healthy young patients with thyrotoxicosis of
recent onset . It is unclear whether our findings are also
applicable to older persons, patients with more prolonged
hyperthyroidism or those with coexistent illnesses . A con-
trol group would have been useful to completely exclude
effects of methodologic and biologic variability . However,
reproducibility data from previous studies (23) indicate that
methodologic and biologic variability are not great enough to
explain the change in left ventricular shortening velocity
observed in the current investigation after T, administration .
Conclusions. This study indicates that in human subjects,
hyperthyroidism of short duration increases the responses of
heart rate and left ventricular shortening velocity to low dose
beta-adrenergic agonist (isoproterenol) infusion . At higher
levels of beta-adrenergic stimulation that elicit a plateau
consistent with maximization of the left ventricular contrac-
tile response, the heart rate-adjusted velocity of left ventric-
ular shortening is not augmented by hyperthyroidism. Thus,
hyperthyroidism of short duration increases heart rate and
left ventricular contractile sensitivity to beta-adrenergic
stimulation in human subjects .
We thank Ali A. Ehsani, MD and Peter B
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